Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Unknown 2 Terminated 2 Withdrawn 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 9 Genitourinary 8 Breast 6 CNS 4 Tumor-Agnostic 3 Thoracic 2 Gastrointestinal 2 Sarcoma 1 Other solid neoplasm 1 Head & Neck 1 Endocrine 1

Conditions

Interventions

pembrolizumab 27 Pemetrexed 10 Nivolumab 10 Cyclophosphamide 10 Carboplatin 10 atezolizumab 8 Specimen Handling 8 Cisplatin 8 Ipilimumab 6 Biopsy 6 fludarabine 5 Injections 5 tislelizumab 4 spartalizumab 4 Vincristine 4 Radiotherapy 4 Proton Therapy 4 Platinum 4 Paclitaxel 4 Drug Therapy 4 Docetaxel 4 Bevacizumab 4 1,2-diaminocyclohexaneplatinum II citrate 4 sintilimab 3 durvalumab 3 Trastuzumab 3 Etoposide 3 Cetuximab 3 zimberelimab 2 trametinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × niraparib × Other solid neoplasm × Clear all

NCT04185831 2024-08-22

MEGALiT

Uppsala University Hospital

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡